| ABCB4, ABCB11 - secventiere NGS* |
9000 |
9000 |
4671 |
| Acetazolamida in sange (ACETA)* |
420 |
378 |
5876 |
| Acetona in urina (ACETU)* |
189 |
170 |
2182 |
| Acid 2-tio-tiazolidin-4-carboxilic in urina (TTCA)* |
300 |
270 |
5971 |
| Acid 5-hidroxindol acetic urinar (5-HIAA) (HIESUT)* |
206 |
185 |
1566 |
| Acid 5-hidroxitriptofan (5-HPT) (H5TRYP)* |
230 |
207 |
5880 |
| Acid 5-hidroxitriptofan in urina (5-HPT) (H5TRYU)* |
220 |
198 |
5881 |
| Acid delta amino-levulinic dehidrataza (ALAD)* |
132 |
119 |
2492 |
| Acid delta amino-levulinic in urina (ALAU)* |
248 |
223 |
2200 |
| Acid fenilglioxilic (PGLYU)* |
106 |
95 |
3290 |
| Acid fenilmercapturic in urina (PMER)* |
439 |
395 |
2208 |
| Acid glutamic in urina (GLUSU)* |
165 |
149 |
3712 |
| Acid hialuronic (HYAS)* |
165 |
149 |
1460 |
| Acid hipuric urinar (AHIPUK)* |
109 |
98 |
2183 |
| Acid homogentisinic (HGENU)* |
407 |
366 |
1483 |
| Acid homovanilic (HVA24)* |
150 |
135 |
2165 |
| Acid homovanilic in LCR* |
297 |
267 |
3268 |
| Acid lipolic (LIPON)* |
320 |
288 |
5877 |
| Acid mandelic in urina (MAND)* |
115 |
104 |
2209 |
| Acid metilhipuric in urina (MHIPPU)* |
230 |
207 |
2184 |
| Acid metilimidazol acetic (metabolit al histaminei) (MIESUK)* |
266 |
239 |
4738 |
| Acid metilmalonic in ser (MMALO)* |
369 |
332 |
5691 |
| Acid metilmalonic in urina (MMALU)* |
359 |
323 |
5692 |
| Acid micofenolic - micofenolat (MYCOP)* |
301 |
271 |
5550 |
| Acid oxalic in ser* |
164 |
148 |
5628 |
| Acid oxalic in urina (OXAU24)* |
164 |
148 |
2185 |
| Acid palmitic (PALM)* |
407 |
366 |
2927 |
| Acid phytanic (PHYT)* |
395 |
356 |
2519 |
| Acid pipecolic (PIPS)* |
374 |
337 |
2665 |
| Acid pristanic (PRIS)* |
451 |
406 |
3017 |
| Acid sialic (SIAL)* |
275 |
248 |
5882 |
| Acid stearic (STEA)* |
407 |
366 |
2928 |
| Acid trans muconic in urina* |
170 |
153 |
4667 |
| Acid tricloracetic in urina (TCLSU)* |
153 |
138 |
2186 |
| Acid uric |
20 |
18 |
577 |
| Acid uric din lichid de punctie (HSP)* |
30 |
27 |
3299 |
| Acid uric urinar** |
28 |
25 |
4 |
| Acid vanil mandelic (VMAT)* |
83 |
75 |
1399 |
| Acidemia glutarica tip 1 - gena GCDH secventiere* |
2500 |
2500 |
4733 |
| Acidemia/acidurie organica si deficienta de cobalamina - panel complex 54 gene - PLUS (ME0901)* |
4600 |
4600 |
5612 |
| Aciduria argininosuccinica (ASL) - Secventiere* |
3000 |
3000 |
4728 |
| Acilcarnitina in urina (CARNU)* |
498 |
448 |
3392 |
| Acizi biliari in materii fecale (GALST)* |
121 |
109 |
3074 |
| Acizi biliari** |
162 |
146 |
1758 |
| Acizi grasi HS-Omega-3-index (HSO3I)* |
450 |
405 |
3432 |
| Acizi grasi liberi (FFS)* |
97 |
87 |
1618 |
| Acizi grasi Omega-3 si Omega-6* |
482 |
434 |
6064 |
| Acizi organici in urina (ORGSU)* |
532 |
479 |
5560 |
| Acondroplazia - gena FGFR3 - secventiere exon 10* |
4000 |
4000 |
5835 |
| ACTH-hormon adenocorticotrop |
81 |
73 |
69 |
| Activitatea Alfa - Sinucleinei in LCR* |
1950 |
1755 |
5951 |
| Activitatea anti Factor X Activat (Heparina) (AFA10A)** |
252 |
227 |
2030 |
| Activitatea anti Factor Xa - Spiegel (Apixaban) (AF10AE)* |
172 |
155 |
4440 |
| Activitatea anti Factor Xa (Rivaroxaban) (AFA10X)* |
187 |
168 |
5254 |
| Activitatea inhibitorie a melanomului (MIA)* |
399 |
359 |
5279 |
| Adalimumab (monitorizarea terapiei) (ADALI)* |
347 |
312 |
3236 |
| ADAMTS13 (factor de clivare von Willebrand) - activitate, anticorpi, antigen (ADAM)* |
727 |
654 |
5900 |
| Adenovirus - Antigen in materii fecale - screening** |
52 |
47 |
1795 |
| Adenovirus - Antigen in materii fecale - test ELISA (ADE)* |
88 |
79 |
2303 |
| Adenovirus Ac IgG (AVGE)* |
73 |
66 |
1841 |
| Adenovirus Ac IgM (AVME)* |
75 |
68 |
1803 |
| Adenovirus ADN-PCR in exsudat faringian/ secretie conjunctivala (AVPCR)* |
650 |
585 |
5800 |
| Adenovirus ADN-PCR in LCR (AVPCL)* |
287 |
258 |
2707 |
| Adenozin-deaminaza - determinare in lichid de punctie (ADDAP)* |
643 |
579 |
4450 |
| Adenozin-deaminaza 2 - test enzimatic (ADA2)* |
1375 |
1238 |
5103 |
| Adenozin-deaminaza in ser (ADDA)* |
695 |
626 |
2738 |
| ADH precursor - CT-Pro-AVP (Provasopresina, Copeptina) (COPEP)* |
223 |
201 |
5693 |
| Adiponectina (ADIN)* |
318 |
286 |
1306 |
| ADN bacterian - PCR in lichid de punctie (ARN 16s) (BAKPCR)* |
287 |
258 |
3579 |
| ADN Mitocondrial - deletii ale genomului mitocondrial pentru sindroamele Kearns-Sayer, Pearson si CPEO* |
1150 |
1150 |
3600 |
| Adrenalina (ADRE)* |
205 |
185 |
1619 |
| Aflatoxine B1, B2, G1, G2 (AFT)* |
450 |
405 |
2631 |
| AFP in lichid amniotic (AFPF)* |
105 |
95 |
2273 |
| AFP-alfa1fetoproteina(ficat,sarcina) |
63 |
57 |
5694 |
| Albumina |
21 |
19 |
6 |
| Albumina din LCR (ALBL)* |
27 |
24 |
1539 |
| Albumina in lichid de punctie (ALBP)* |
40 |
36 |
2883 |
| Alcool etilic (etanol) in urina - screening** |
30 |
27 |
5955 |
| Alcool metilic (metanol) in sange-EDTA (MALK)* |
230 |
207 |
2298 |
| Alcool metilic (metanol) in urina* |
245 |
221 |
5746 |
| Aldolaza in ser (ALDOL)* |
160 |
144 |
1314 |
| Aldosteron (ALDOS)** |
184 |
166 |
1358 |
| Aldosteron in urina (ALDOSU)* |
189 |
170 |
1640 |
| ALEX 2 (Allergy Explorer - test multiplex IgE specific 295 alergeni)** |
856 |
770 |
5091 |
| Alfa - talasemie - testare genetica (HBA1)* |
2609 |
2609 |
6065 |
| Alfa 1 Antitripsina (AAT)** |
60 |
54 |
1295 |
| Alfa 1 Antitripsina fenotipare (AATPT)* |
165 |
149 |
1881 |
| Alfa 1 Antitripsina in materii fecale (AATST)* |
383 |
345 |
1771 |
| Alfa 1 Glicoproteina (A1GLY)* |
120 |
108 |
1556 |
| Alfa 1 Microglobulina (A1MI)* |
95 |
86 |
5650 |
| Alfa 1 Microglobulina in urina 24H (A1MUT)* |
95 |
86 |
5652 |
| Alfa 1 Microglobulina in urina spontana (A1MIUK)* |
104 |
94 |
5651 |
| Alfa 1-antitripsina (SERPINA1) - genotipare ARMS-PCR* |
450 |
450 |
4548 |
| Alfa 1-antitripsina (SERPINA1) - secventierea* |
1600 |
1600 |
4549 |
| Alfa 2 Macroglobulina (A2MA)* |
83 |
75 |
1466 |
| Alfa Enolaza - BLOT (AENO)* |
138 |
124 |
5072 |
| Alfa Glucozidaza 1 (AGLU1)* |
248 |
223 |
3559 |
| Alfa Glucozidaza in sperma (GLUAEJ)* |
180 |
162 |
5860 |
| Alfa-2 antiplasmina (inhibitor de plasmina) (A2APL)* |
205 |
185 |
5499 |
| Alfa-Galactozidaza in ser (AGAL)* |
90 |
81 |
3444 |
| Alfa-Iduronidaza - MPZ I Hurler-Scheie (AIDU)* |
220 |
198 |
2316 |
| Alfa-N-acetilgalactozaminidaza(Nagalaza) (NAGA)* |
638 |
574 |
3330 |
| Alfa1-antitripsina - genotipare (PiM, PiZ, PiS)* |
960 |
960 |
6171 |
| Alternate complement- activitate* |
220 |
198 |
6111 |
| Aluminiu seric (AL)* |
131 |
118 |
2188 |
| Aluminiu urinar (ALU)* |
174 |
157 |
1617 |
| AMA - anticorpi anti-mitocondriali (AMA)** |
201 |
181 |
1400 |
| AMA-M2 (AMA2)* |
85 |
77 |
1736 |
| AMA-M9 (AMA9)* |
105 |
95 |
3282 |
| Amantadina (AMANT)* |
400 |
360 |
4844 |
| Amfetamine (AMP) in urina - screening** |
106 |
95 |
3054 |
| Amfetamine in firul de par (AMPHAA)* |
386 |
347 |
4347 |
| Amfetamine in urina - confirmare si identificare (AMPUBU)* |
386 |
347 |
3576 |
| Amfetamine/Metamfetamine - test de screening in ser (AMPHSE)* |
387 |
348 |
2014 |
| Amilaza |
22 |
20 |
40 |
| Amilaza - izoenzime (alfa-amilaza, amilaza pancreatica, amilaza salivara) (AMISO)* |
178 |
160 |
2325 |
| Amilaza in lichid de punctie (AMYLP)* |
28 |
25 |
2176 |
| Amilaza pancreatica serica** |
25 |
23 |
1634 |
| Amilaza urinara (AMY24)* |
24 |
22 |
41 |
| Amilaza urinara (urina spontana)* |
12 |
11 |
4905 |
| Amiloid A in ser (SAA)* |
125 |
113 |
2942 |
| Amine biogene in LCR (acid homovanilic, acid 5-hidroxiindolacetic, 3-orto-metildopa, L-Dopa, 5-hidroxitriptofan, raport HVA) (BIOL)* |
1073 |
966 |
4988 |
| Aminoacizi din picatura de sange pe hartie-filtru (AMSFI)* |
440 |
396 |
3362 |
| Aminoacizi screening in LCR (AMINOL)* |
462 |
416 |
4713 |
| Aminoacizi screening in plasma (AMSPP)* |
690 |
621 |
1589 |
| Aminoacizi screening in urina (AMINOU)* |
358 |
322 |
1836 |
| Amiodarona in ser (AMI)* |
341 |
307 |
2135 |
| Amiotrofie spinala (genele SMN1 si SMN 2) - MLPA* |
2000 |
2000 |
5507 |
| Amiotrofie spinala tip I/II/III gena SMN 1 in lichid amniotic* |
5100 |
5100 |
1814 |
| Amiotrofie spinala tip I/II/III gena SMN 1 in vilozitati coriale* |
4250 |
4250 |
3002 |
| Amitriptilina si metabolitul Nortriptilina (AMNO)* |
250 |
225 |
4856 |
| Amniocultura** |
170 |
153 |
2896 |
| Amoxicillin (AMOXI)* |
445 |
401 |
5558 |
| Amprenta anala** |
48 |
43 |
1389 |
| ANA - PANEL 23 ANTIGENE NUCLEARE BLOT EXTINS (ADNds, nucleosome, histone, SS-A, Ro52, SS-B, nRNP/Sm, Mi-2 beta, Mi-2 alfa, Ku, CENP A, CENP B, Sp100, PML, Scl 70, PM-Scl 100, PM-Scl 75, RP 11, RP 155, gp 210, PCNA, DFS 70)** |
275 |
248 |
4822 |
| ANA - PANEL 3 BLOT EXTINS (U1nRNP, Sm, SS-A, Ro52, SS-B, Scl-70, Pm-Scl, Jo-1, Centromer B, PCNA, ADNds, Nucleosom, Histone, Proteina P ribosomala, AMA-M2, DFS-70)** |
200 |
180 |
4776 |
| ANA - screening Ac IgG - Imunofluorescenta** |
68 |
61 |
2615 |
| ANA - screening si titrare Ac IgG - Imunofluorescenta** |
106 |
95 |
1290 |
| ANA - titrare Ac IgA, IgG, IgM - Imunofluorescenta** |
235 |
212 |
5695 |
| Analiza firului de par (elemente toxice si minerale) - test extins (MMINPE)* |
1290 |
1161 |
3327 |
| Analiza firului de par (elemente toxice si minerale) - test standard (MMINPH)* |
990 |
891 |
3326 |
| Analiza mutatiilor familiale cunoscute in genele MSH6 si BPTF* |
1100 |
1100 |
5378 |
| ANCA (cANCA+pANCA)* |
231 |
208 |
1371 |
| Androgen index-free (FAI)* |
165 |
149 |
1945 |
| Androstandiol glucuronid (ANDOL)* |
187 |
168 |
3239 |
| Androstendion seric (ANDRO)** |
184 |
166 |
1369 |
| Anemia Diamond-Blackfan - panel complex de 14 de gene - PLUS, SEQ, DEL/DUP (HE0901)* |
3600 |
3600 |
5471 |
| Aneuploidii in alte produse biologice (X, Y, 13, 18, 21) - QF-PCR* |
600 |
600 |
4928 |
| Aneuploidii in lichid amniotic (X, Y, 13, 18, 21) - QF-PCR* |
700 |
700 |
3681 |
| Aneuploidii in sange EDTA (X, Y, 13, 18, 21) - QF-PCR* |
600 |
600 |
4927 |
| Aneuploidii in sperma (X, Y, 13, 15, 16, 17, 18, 21, 22) - FISH* |
2900 |
2900 |
5382 |
| Aneuploidii in sperma (X, Y, 13, 16, 18, 21, 22) - FISH* |
1500 |
1500 |
5383 |
| Aneuploidii in sperma (X, Y, 13, 18, 21) - FISH* |
1400 |
1400 |
4771 |
| Aneuploidii in sperma (X, Y, 18) - FISH* |
1300 |
1300 |
5381 |
| Aneuploidii X-Y (analiza sexului cromosomial)* |
650 |
650 |
5384 |
| Angioedem ereditar - gena SERPING1 - secventiere* |
1500 |
1500 |
5510 |
| Angioedem ereditar tip III - gena factor 12 - secventiere* |
5200 |
5200 |
4961 |
| Angiotensina II (ANGIO2)* |
295 |
266 |
5126 |
| Angiotensinconvertaza (ACE)* |
95 |
86 |
5682 |
| Angiotensinconvertaza in LCR (ACEL)* |
109 |
98 |
3424 |
| Anisakis Ac IgG (ANISGI)* |
99 |
89 |
4445 |
| Anti Factor II - Activitate (Dabigatran-Pradaxa) (AFA2D)* |
165 |
149 |
4441 |
| Anti Mulleriane Hormone (AMH) |
227 |
204 |
1532 |
| Anti Receptor TSH (TRAB)** |
142 |
128 |
612 |
| Anti-asialoglicoprotein receptor (ASGP-R)* |
130 |
117 |
5836 |
| Anti-IgLON5 in LCR (IGL5IL)* |
245 |
221 |
5885 |
| Anti-IgLON5 in ser (IGLO5I)* |
310 |
279 |
5811 |
| Antibiograma (la cerere) |
20 |
18 |
3068 |
| Anticoagulant Lupic (LAB)** |
184 |
166 |
1415 |
| Anticorpi ADA (Adalimumab) (anticorpi anti-TNF-alfa - eficienta terapeutica) (ADALAK)* |
204 |
184 |
3237 |
| Anticorpi anti - Imunoglobulina A (IGAA)* |
209 |
188 |
4721 |
| Anticorpi anti - mGluR5 - IgG (MGLUR5)* |
105 |
95 |
5770 |
| Anticorpi anti acetilcolin receptor (ACRH)* |
182 |
164 |
1453 |
| Anticorpi anti acini de glanda salivara (SPEIAZ)* |
94 |
85 |
2071 |
| Anticorpi anti actina (ACTA)* |
110 |
99 |
2116 |
| Anticorpi anti ADN dublu catenar-DS (DDNSE)* |
88 |
79 |
1307 |
| Anticorpi anti ADN dublu catenar-DS in LCR (DDNSEL)* |
132 |
119 |
2752 |
| Anticorpi anti ADN monocatenar-SS (SDNSE)* |
109 |
98 |
1449 |
| Anticorpi anti adreno-cortex (NNA)* |
105 |
95 |
1692 |
| Anticorpi anti Agrin IgG (AGRING)* |
170 |
153 |
5921 |
| Anticorpi anti Amfifizina (AMPHI1)* |
250 |
225 |
5878 |
| Anticorpi anti Amfifizina 1 in LCR (AMPH1L)* |
250 |
225 |
5867 |
| Anticorpi anti Annexin V IgG (ANNV)* |
110 |
99 |
1902 |
| Anticorpi anti Aspergillus fumigatus (ASFUH)* |
348 |
313 |
1797 |
| Anticorpi anti Aspergillus fumigatus IgA (ASFAE2)* |
306 |
275 |
5546 |
| Anticorpi anti Aspergillus fumigatus IgG (ASFGE2)* |
306 |
275 |
5547 |
| Anticorpi anti Aspergillus fumigatus IgM (ASFME2)* |
306 |
275 |
5548 |
| Anticorpi anti BPI (proteine ce cresc permeabilitatea bactericida) (BPI)* |
135 |
122 |
5902 |
| Anticorpi anti canal de calciu tip N in LCR (CAKNL)* |
330 |
297 |
2745 |
| Anticorpi anti canal de calciu tip PQ in LCR (CAKPQL)* |
330 |
297 |
2746 |
| Anticorpi anti canale de potasiu in LCR (KKAKL)* |
220 |
198 |
5813 |
| Anticorpi anti canale de potasiu voltaj-dependente (KKAK)* |
259 |
233 |
2158 |
| Anticorpi anti Candida albicans IgA (CANAE)* |
90 |
81 |
2118 |
| Anticorpi anti Candida albicans IgG (CANGE)* |
110 |
99 |
2119 |
| Anticorpi anti Candida albicans IgM (CANME)* |
110 |
99 |
2120 |
| Anticorpi anti Cardiolipina IgA* |
150 |
135 |
6097 |
| Anticorpi anti Cardiolipina IgG, IgM* |
145 |
131 |
6096 |
| Anticorpi anti CASPR2 (Contactin-associated protein 2) in LCR (CASPRL)* |
245 |
221 |
5870 |
| Anticorpi anti CASPR2 (Contactin-associated protein 2) in ser (CASPR2)* |
250 |
225 |
5931 |
| Anticorpi anti catepsina G (CATG)* |
115 |
104 |
5915 |
| Anticorpi anti CCP - Peptidul ciclic citrulinat** |
140 |
126 |
1392 |
| Anticorpi anti celula endoteliala (EZA)* |
145 |
131 |
2203 |
| Anticorpi anti celule insulare (ICAT)* |
312 |
281 |
1504 |
| Anticorpi anti celule parietale gastrice (PARIA)** |
183 |
165 |
1606 |
| Anticorpi anti centromer** |
97 |
87 |
5689 |
| Anticorpi anti citocrom P450-c17-hidroxilaza (PC17H)* |
105 |
95 |
2405 |
| Anticorpi anti citocrom P450-scc-hidroxilaza (PSCCH)* |
90 |
81 |
2404 |
| Anticorpi anti colagen tip VII IgG (KOLL7)* |
115 |
104 |
5789 |
| Anticorpi anti Contactin 1 in LCR (CNTN1L)* |
281 |
253 |
5117 |
| Anticorpi anti Contactin 1 in ser (CASPR1)* |
282 |
254 |
5116 |
| Anticorpi anti CRMP5 in LCR (Oligodendrocite) (CRMP5L)* |
145 |
131 |
2584 |
| Anticorpi anti CRMP5 in ser (Oligodendrocite) (CRMP5)* |
143 |
129 |
2585 |
| Anticorpi anti CV-2 in LCR (CV2L)* |
250 |
225 |
5794 |
| Anticorpi anti desmozom (pemfigus) (STAK)* |
330 |
297 |
2491 |
| Anticorpi anti DFS 70 (DFS70)* |
121 |
109 |
3588 |
| Anticorpi anti Endomysium IgA (EMAA)* |
127 |
114 |
1526 |
| Anticorpi anti Endomysium IgG (EMAG)* |
182 |
164 |
1527 |
| Anticorpi anti Endomysium IgM* |
132 |
119 |
4426 |
| Anticorpi anti Entamoeba histolytica (AMOGI)* |
121 |
109 |
1580 |
| Anticorpi anti enterocitari (AIE)* |
209 |
188 |
2267 |
| Anticorpi anti epiteliu acini de glanda salivara (SPEIBA)* |
105 |
95 |
2072 |
| Anticorpi anti eritrocitari - SCREENING** |
250 |
225 |
3110 |
| Anticorpi anti eritrocitari - TITRARE** |
245 |
221 |
4427 |
| Anticorpi anti eritropoietina (ERYTH)* |
213 |
192 |
3050 |
| Anticorpi anti factor intrinsec** |
349 |
314 |
1518 |
| Anticorpi anti factor IX (AFA9)* |
163 |
147 |
3029 |
| Anticorpi anti factor VIII (AFA8)* |
130 |
117 |
5677 |
| Anticorpi anti Fasciola Hepatica (FASE)* |
236 |
212 |
4533 |
| Anticorpi anti fodrin (spectrina non-eritroida) IgA (FODAE)* |
120 |
108 |
2572 |
| Anticorpi anti fodrin (spectrina non-eritroida) IgG (FODGE)* |
120 |
108 |
2573 |
| Anticorpi anti fosfatidil-etanolamina IgG (PHETG)* |
65 |
59 |
2720 |
| Anticorpi anti fosfatidil-etanolamina IgM (PHETM)* |
65 |
59 |
2721 |
| Anticorpi anti fosfatidil-glicerol IgG (PHGLG)* |
78 |
70 |
3363 |
| Anticorpi anti fosfatidil-glicerol IgM (PHGLM)* |
78 |
70 |
3323 |
| Anticorpi anti fosfatidil-inozitol IgG (PHING)* |
78 |
70 |
3119 |
| Anticorpi anti fosfatidil-inozitol IgM (PHINM)* |
90 |
81 |
3120 |
| Anticorpi anti fosfatidil-serina IgA (PHSEA)* |
115 |
104 |
5729 |
| Anticorpi anti fosfatidil-serina IgG (PHSEG)* |
115 |
104 |
5730 |
| Anticorpi anti fosfatidil-serina IgM (PHSEM)* |
115 |
104 |
5731 |
| Anticorpi anti Fosfolipidici IgG* |
77 |
69 |
1326 |
| Anticorpi anti Fosfolipidici IgM* |
77 |
69 |
1777 |
| Anticorpi anti gangliozide-mielina 1 IgG (GM1G)* |
160 |
144 |
2812 |
| Anticorpi anti gangliozide-mielina 1 IgG in LCR (GMGL)* |
106 |
95 |
2780 |
| Anticorpi anti gangliozide-mielina 1 IgM (GM1M)* |
160 |
144 |
2813 |
| Anticorpi anti gangliozide-mielina 1 IgM in LCR (GMML)* |
106 |
95 |
2781 |
| Anticorpi anti gangliozide-mielina 2 IgG (GM2G)* |
106 |
95 |
3075 |
| Anticorpi anti gangliozide-mielina 2 IgM (GM2M)* |
106 |
95 |
3076 |
| Anticorpi anti Glicoproteina oligodendrocitara a mielinei (MOGI)** |
250 |
225 |
5907 |
| Anticorpi anti Glicoproteina oligodendrocitara a mielinei in LCR (MOGIL)* |
245 |
221 |
5879 |
| Anticorpi anti GM-CSF (Granulocite-Macrofage)* |
150 |
135 |
6017 |
| Anticorpi Anti grup sangvin A - detectie** |
74 |
67 |
3727 |
| Anticorpi Anti grup sangvin A - titrare** |
110 |
99 |
3730 |
| Anticorpi Anti grup sangvin B - detectie** |
66 |
59 |
3728 |
| Anticorpi Anti grup sangvin B - titrare** |
110 |
99 |
3731 |
| Anticorpi Anti grup sangvin RHo(D) - detectie si identificare** |
74 |
67 |
3726 |
| Anticorpi Anti grup sangvin RHo(D) - titrare** |
160 |
144 |
3729 |
| Anticorpi anti Haemophilus influenzae tip B IgG postvaccinali (HIBGE)* |
200 |
180 |
5097 |
| Anticorpi anti hialuronidaza (AHYA)* |
109 |
98 |
5749 |
| Anticorpi anti HMG-CoA-reductaza (HMGCR)* |
115 |
104 |
5040 |
| Anticorpi anti Hu-D (HU)* |
105 |
95 |
1888 |
| Anticorpi anti Hu-D in LCR - BLOT (HUBL)* |
200 |
180 |
5732 |
| Anticorpi anti Hu-D in LCR (HUL)* |
105 |
95 |
2703 |
| Anticorpi anti infliximab (INFXAK)* |
204 |
184 |
3125 |
| Anticorpi anti influenza A IgA (INAAE)* |
106 |
95 |
3394 |
| Anticorpi anti influenza A IgG (INAGE)* |
111 |
100 |
3395 |
| Anticorpi anti influenza B IgA (INBAE)* |
111 |
100 |
3397 |
| Anticorpi anti influenza B IgG (INBGE)* |
111 |
100 |
3398 |
| Anticorpi anti insulina (IAA)* |
206 |
185 |
1503 |
| Anticorpi anti interferon alfa (AINFE)* |
199 |
179 |
4643 |
| Anticorpi anti interferon beta (BINFE)* |
260 |
234 |
3372 |
| Anticorpi anti Jo-1 (JO1)* |
97 |
87 |
1710 |
| Anticorpi anti Ku (KUB)* |
198 |
178 |
1813 |
| Anticorpi anti LC1 (LC1)* |
178 |
160 |
5364 |
| Anticorpi anti LGI1 in LCR (LGI1L)* |
330 |
297 |
5812 |
| Anticorpi anti LGI1 in ser (encefalita limbica) (LGI1)* |
330 |
297 |
5795 |
| Anticorpi anti MDA5 - BLOT (MDA5B)* |
106 |
95 |
4691 |
| Anticorpi anti membrana bazala alveolara (ALVBA)* |
98 |
88 |
3297 |
| Anticorpi anti membrana bazala epidermala (EBMA)* |
213 |
192 |
2414 |
| Anticorpi anti membrana bazala glomerulara (GBMC)* |
97 |
87 |
5688 |
| Anticorpi anti Meningococcus IgG (MENAK)* |
1981 |
1783 |
5018 |
| Anticorpi anti Mi 2 (MI2)* |
143 |
129 |
1811 |
| Anticorpi anti microzomiali - LKM1* |
96 |
86 |
1283 |
| Anticorpi anti mielina asociata glycoproteinei IgM in LCR (MAGL)* |
250 |
225 |
5871 |
| Anticorpi anti miocard (HMA)* |
271 |
244 |
1929 |
| Anticorpi anti muschi cardiac* |
200 |
180 |
6055 |
| Anticorpi anti muschi neted (ASMA)* |
150 |
135 |
5367 |
| Anticorpi anti muschi striat (SKMA)* |
138 |
124 |
1648 |
| Anticorpi anti MuSK (tirozinkinaza musculara) (RTYRA)* |
230 |
207 |
1914 |
| Anticorpi anti Mycoplasma hominis/Ureaplasma urealyticum IgG** |
138 |
124 |
1586 |
| Anticorpi anti myosin (MYOA)* |
110 |
99 |
1649 |
| Anticorpi anti natalizumab (TYSABRI) * |
182 |
164 |
3373 |
| Anticorpi anti neurofascin 140 in ser* |
656 |
590 |
5118 |
| Anticorpi anti neurofascin 155 in ser (NF155)* |
293 |
264 |
5528 |
| Anticorpi anti neurofascin 186 in ser (NF186)* |
293 |
264 |
5529 |
| Anticorpi anti Neurofilamente (NEUFI)* |
250 |
225 |
5887 |
| Anticorpi anti Neurofilamente in LCR (NEUFIL)* |
250 |
225 |
5886 |
| Anticorpi anti neuronali - Hu-D, Ri, Yo (NEURO)* |
327 |
294 |
2136 |
| Anticorpi anti neuronali - NMDAR, AMPAR, GABABR, LGI1, CASPR2, GABAAR, mGluR1, mGluR2, mGluR5, DPPX, IGLON5, Neurexin, Gluk2, SEZ6L2 - in LCR * |
1790 |
1611 |
6003 |
| Anticorpi anti neuronali - NMDAR, AMPAR, GABABR, LGI1, CASPR2, GABAAR, mGluR1, mGluR2, mGluR5, DPPX, IGLON5, Neurexin, Gluk2, SEZ6L2* |
1595 |
1436 |
6002 |
| Anticorpi anti neuronali BLOT - Amphiphysin, CV2, PNMA2 (Ma2/Ta), Ri, Yo, Hu, Recoverin, AGNA (SOX1), Titin (MGT - 30)** |
530 |
477 |
5957 |
| Anticorpi anti neuronali CV2 in ser - BLOT (CV2B)* |
149 |
134 |
2968 |
| Anticorpi anti neuronali Ma1 in LCR (MA1L)* |
105 |
95 |
2774 |
| Anticorpi anti neuronali Ma2 in LCR (MA2L)* |
250 |
225 |
5869 |
| Anticorpi anti neuronali Ma2/Ta (MA2)* |
250 |
225 |
5872 |
| Anticorpi anti NOR-90 (NOR90)* |
78 |
70 |
1942 |
| Anticorpi anti nucleotidaza cN-1A IgG (miozita sIBM) (MUP44)* |
138 |
124 |
5513 |
| Anticorpi anti nucleozom (NUCLEC)* |
116 |
104 |
2917 |
| Anticorpi anti ovarieni (OVAK)* |
248 |
223 |
1968 |
| Anticorpi anti PCA-2 in LCR (PCAL)* |
250 |
225 |
5914 |
| Anticorpi anti PCNA (Proliferating Cell Nuclear Antigen)(Ciclina)** |
85 |
77 |
3066 |
| Anticorpi anti PDGFR beta (PDGFRB)* |
106 |
95 |
4783 |
| Anticorpi anti pituitari (APA) (HYPA)* |
95 |
86 |
3568 |
| Anticorpi anti PM/Scl (PMSCL)* |
154 |
139 |
1901 |
| Anticorpi anti Pneumococ IgG postvaccinali (Streptococcus pneumoniae anticorpi anti capsula polizaharidica 1-5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 20, 22F, 23F, 33F) (PNGE)* |
110 |
99 |
2839 |
| Anticorpi anti Polioma JCV-virus in LCR (JCVAKL)* |
185 |
167 |
5976 |
| Anticorpi anti Polioma JCV-virus in ser (JCVAK)* |
185 |
167 |
5975 |
| Anticorpi anti proteina acida gliala fibrilara IgG (GFAPG)* |
300 |
270 |
5847 |
| Anticorpi anti proteina acida gliala fibrilara IgG in LCR (GFAPGL)* |
330 |
297 |
5848 |
| Anticorpi anti proteina bazica a mielinei (MBP)* |
250 |
225 |
5796 |
| Anticorpi anti proteina bazica a mielinei in LCR (MBPL)* |
271 |
244 |
5868 |
| Anticorpi anti Proteina-P ribozomala (RIBGE)* |
201 |
181 |
1960 |
| Anticorpi anti proteine histone (HISTO)* |
236 |
212 |
5790 |
| Anticorpi anti quadrosialo gangliozid IgG (GQ1b) (GQ1BG)* |
106 |
95 |
3129 |
| Anticorpi anti receptor A2-Fosfolipaza IgG (PLA2RE)* |
150 |
135 |
3550 |
| Anticorpi anti receptor AMPA (GluR1, GluR2, AMPA-r) (AMPAR)* |
295 |
266 |
5935 |
| Anticorpi anti receptor AMPA in LCR (AMPARL)* |
121 |
109 |
5939 |
| Anticorpi anti receptor de glicina (GLYCR)* |
260 |
234 |
5793 |
| Anticorpi anti receptor GABA-A tip IgG in LCR (GABAAL)* |
260 |
234 |
5954 |
| Anticorpi anti receptor GABA-A tip IgG in ser (GABAAR)* |
260 |
234 |
6029 |
| Anticorpi anti receptor GABA-B in LCR* |
250 |
225 |
5894 |
| Anticorpi anti receptor GABA-B in ser* |
250 |
225 |
5893 |
| Anticorpi anti receptor GABA-B tip IgG in LCR (GABABL)* |
250 |
225 |
5903 |
| Anticorpi anti receptor GABA-B tip IgG in ser (GABABR)* |
250 |
225 |
5904 |
| Anticorpi anti receptor glutamat (NMDA) IgA (NMDARA)* |
250 |
225 |
5797 |
| Anticorpi anti receptor glutamat (NMDA) in LCR (NMDARL)* |
295 |
266 |
2640 |
| Anticorpi anti receptor muscarinic M3 de acetilcolina (ACHM3)* |
220 |
198 |
5963 |
| Anticorpi anti receptor Ryanodin (RYR)* |
121 |
109 |
3183 |
| Anticorpi anti Reticulina IgA* |
135 |
122 |
5641 |
| Anticorpi anti Reticulina IgG* |
135 |
122 |
5642 |
| Anticorpi anti Ri (RI)* |
144 |
130 |
2130 |
| Anticorpi anti Ri in LCR - BLOT (RIBL)* |
200 |
180 |
5733 |
| Anticorpi anti Ri in LCR (RIL)* |
105 |
95 |
2704 |
| Anticorpi anti ribonucleoproteine - U1-RNP/Sm (RNPSM)* |
111 |
100 |
5280 |
| Anticorpi anti Saccharomyces cerevisiae IgA, IgG (ASCA)* |
403 |
363 |
6076 |
| Anticorpi anti Saccharomyces cerevisiae IgM (SCEMI)* |
121 |
109 |
1525 |
| Anticorpi anti Scl 70 (SCL70)* |
100 |
90 |
1410 |
| Anticorpi anti spermatozoizi (SPAK)* |
170 |
153 |
1404 |
| Anticorpi anti SRP (SRP)* |
121 |
109 |
1812 |
| Anticorpi anti SS-A-Ro (SSA)* |
94 |
85 |
1302 |
| Anticorpi anti SS-B-La (SSB)* |
96 |
86 |
1303 |
| Anticorpi anti stafilolizina (ASTA)* |
122 |
110 |
1428 |
| Anticorpi anti steroid 21-hidroxilaza (PC21H)* |
213 |
192 |
2134 |
| Anticorpi anti streptodornaza (streptococci DNAse-B) (DORN)* |
130 |
117 |
1430 |
| Anticorpi anti Strongyloides - Westernblot (STROW)* |
318 |
286 |
5807 |
| Anticorpi anti Tetanus (TETE)* |
100 |
90 |
2302 |
| Anticorpi anti tiroglobulina |
58 |
52 |
623 |
| Anticorpi anti Tirozin-fosfataza (IA2)* |
189 |
170 |
2057 |
| Anticorpi anti Titin (MGT-30) (TITIN)* |
207 |
186 |
2582 |
| Anticorpi anti toxina Difterica (DIPE)* |
77 |
69 |
3366 |
| Anticorpi anti Tr (TR)* |
220 |
198 |
5901 |
| Anticorpi anti trombocitari legati IgG si IgM (THRAL)* |
187 |
168 |
2401 |
| Anticorpi anti trombocitari liberi - receptori de fibrinogen, von Willebrand si colagen (THRAF)* |
797 |
717 |
2402 |
| Anticorpi anti trombocitari liberi si legati (THROA)* |
770 |
693 |
1631 |
| Anticorpi anti U3-nRNP Fibrilarina (U3RNP)* |
130 |
117 |
1940 |
| Anticorpi anti Vimentina Citrulinata Mutanta (anti-MCV) (MCVAK)* |
165 |
149 |
2314 |
| Anticorpi anti virus parainfluenza tip 1,2,3 IgA (PIAE)* |
100 |
90 |
4768 |
| Anticorpi anti virus rabic (TOLN)* |
130 |
117 |
1375 |
| Anticorpi anti Yo (YO)* |
120 |
108 |
2131 |
| Anticorpi anti Yo in LCR - BLOT (YOBL)* |
200 |
180 |
5734 |
| Anticorpi anti Yo in LCR (YOL)* |
105 |
95 |
2705 |
| Anticorpi anti-beta2 glicoproteina1 - IgA* |
100 |
90 |
6079 |
| Anticorpi anti-beta2 glicoproteina1 - IgG, IgM* |
200 |
180 |
6084 |
| Anticorpi anti-canale de calciu (tip N si PQ)* |
621 |
559 |
6141 |
| Anticorpi anti-desmoglein 1 si 3 (DSG 1 si 3)* |
640 |
576 |
6130 |
| Anticorpi anti-fosfatidilserina IgG/IgM/IgA* |
178 |
160 |
6119 |
| Anticorpi anti-gangliozide (IgG/IgM)* |
518 |
466 |
6091 |
| Anticorpi anti-glicoproteina asociata mielinei (MAG)* |
409 |
368 |
6138 |
| Anticorpi anti-neurocondrina (NEUCH)* |
300 |
270 |
6022 |
| Anticorpi anti-protrombina, IgG* |
116 |
104 |
6157 |
| Anticorpi anti-protrombina, IgM* |
116 |
104 |
6158 |
| Anticorpi anti-receptor de glicina in LCR (GLYCRL)* |
300 |
270 |
5775 |
| Anticorpi anti-receptor glutamat (tip NMDA) in ser* |
159 |
143 |
6071 |
| Anticorpi anti-RNS polimeraza III* |
280 |
252 |
6163 |
| Anticorpi anti-SLA/LP* |
152 |
137 |
6095 |
| Anticorpi anti-transportor de zinc 8* |
329 |
296 |
4398 |
| Anticorpi Antinucleari Sm (SM)* |
92 |
83 |
1291 |
| Anticorpi PR3 - Proteinaza 3 (PR3C)* |
83 |
75 |
4468 |
| Anticorpi Treponema pallidum* |
57 |
51 |
6156 |
| Antidepresive in urina (ADEPU)* |
390 |
351 |
3270 |
| Antidepresive triciclici in ser (TRIC)* |
335 |
302 |
2020 |
| Antitrombina – Antigen (ATAG)* |
204 |
184 |
5127 |
| Antitrombina III** |
70 |
63 |
1454 |
| Aortopatie - panel complex de 53 de gene - PLUS, SEQ, DEL/DUP (CA1001)* |
4600 |
4600 |
5421 |
| APCR - rezistenta la activarea proteinei C (APC)* |
125 |
113 |
1455 |
| Apolipoproteina A1 si Apolipoproteina B - test genetic hiperlipidemie (gena APOA1, gena APOB)* |
2650 |
2650 |
3249 |
| Apolipoproteina A1* |
77 |
69 |
1386 |
| Apolipoproteina A2 (APOLA2)* |
85 |
77 |
1601 |
| Apolipoproteina B* |
34 |
31 |
1388 |
| Apolipoproteina C2* |
440 |
396 |
4766 |
| Apolipoproteina E (APOLE)* |
97 |
87 |
2838 |
| Apolipoproteina E genotipare** |
521 |
521 |
5273 |
| Aquaporin 4 (Neuromielita optica) Ac IgG** |
245 |
221 |
6006 |
| Aquaporin 4 (Neuromielita optica) Ac totali in LCR** |
500 |
450 |
6007 |
| Argint in ser (AG)* |
165 |
149 |
5638 |
| Arilsulfataza A serica (ARSUA)* |
163 |
147 |
5874 |
| Arilsulfataza A urinara (ARSUAU)* |
200 |
180 |
5875 |
| Arilsulfataza B - MPZ VI Maroteaux-Lamy (ARSUB)* |
220 |
198 |
2318 |
| Aripiprazol (ARIPI)* |
300 |
270 |
5760 |
| Aritmia - panel complex de 58 de gene - PLUS, SEQ, DEL/DUP (CA1601)* |
4600 |
4600 |
5189 |
| Arsenic in sange (AS)* |
153 |
138 |
1980 |
| Arsenic in urina (ASU)* |
153 |
138 |
2207 |
| Ascaris Ac IgG (adult) (ASCE)* |
220 |
198 |
1861 |
| ASLO (test cantitativ) |
32 |
29 |
131 |
| Aspergillus fumigatus ADN-PCR (AFPCR)* |
387 |
348 |
5358 |
| Aspergillus galactomanan - Antigen in ser (ASAGE)* |
121 |
109 |
2160 |
| Ataxia - panel 257 gene - PLUS, SEQ, DEL/DUP (NE2101)* |
5200 |
5200 |
5435 |
| Ataxia Friedreich (FRDA gene)* |
1500 |
1500 |
1764 |
| Ataxia spinocerebelara de tip 3 (SCA3 gene)* |
1000 |
1000 |
4661 |
| Atenolol (ATENO)* |
390 |
351 |
4647 |
| ATPO - Ac anti tiroperoxidaza |
68 |
61 |
88 |
| Atrezia gastrointestinala - panel complex de 15 gene - PLUS, SEQ, DEL/DUP (MA2801)* |
3600 |
3600 |
5476 |
| Atrichia congenitala - mutatia genei HER (hairless gene)* |
18000 |
18000 |
4963 |
| Atrofia musculara spinala - gena SMN1 - secventiere Sanger* |
2950 |
2950 |
5516 |
| Atrofie musculara spinala si bulbara (SBMA) (Boala Kennedy)-gena AR (KENNED)* |
1500 |
1500 |
3233 |
| Aur in ser (AU)* |
417 |
375 |
2347 |
| Aur in urina (AUU)* |
384 |
346 |
2910 |
